AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4948.00p Today's change: -0.24%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4948.00p 5 day change: +0.64%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4948.00p 6 month change: -0.88%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]

19 March 2017
Views
376

Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]

17 March 2017
Views
240

Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]

15 March 2017
Shares
25
Views
527

AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]

20 February 2017
Views
213

AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]

2 February 2017
Views
503

AstraZeneca is forecast to report disappointing results this week as competition continues to drag on sales. [...]

29 January 2017
Views
566

London's top share index hit a fresh all-time high yesterday, setting a record for the longest winning streak [...]

11 January 2017
Shares
15
Views
310

2016's events made fools of most pundits, and looking back at my column exactly a year ago, I fared little better. [...]

6 January 2017
Shares
9
Views
1,259

Pharmaceutical giant AstraZeneca has bagged $550m (£446m) in an initial payment from the sale of its late-stage [...]

23 December 2016
Shares
7
Views
481

AstraZeneca's biological arm MedImmune and US life sciences group Abpro have joined forces on a new research [...]

30 November 2016
Shares
2
Views
195

FTSE 100 pharma firm Hikma has cut its full-year sales guidance for its US generics business to roughly $600m, [...]

10 November 2016
Shares
2
Views
403

AstraZeneca posted weak quarterly profits this morning, but big pharma companies are expected to benefit from [...]

10 November 2016
Views
159

Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]

9 November 2016
Shares
5
Views
600

Drug giant AstraZeneca, which reports its third quarter results on Thursday, is expected to remain under pressure [...]

6 November 2016
Shares
1
Views
331

Pharmaceuticals bosses are set to meet with ministers next month in a bid to press their case for government support [...]

30 October 2016
Shares
2
Views
493

Content tagged with "AstraZeneca"